The need for continued education is critical in these uncertain times. Therefore, the co-directors of the Fall Clinical Dermatology Conference are excited to announce our new program: the Fall Clinical Virtual Grand Rounds (FCVGR). This new online series is designed to help maintain the educational opportunities one would have if they were able to attend grand rounds in person.

FCVGR will consist of eight weekly CME sessions on a variety of dermatological diseases and tools.

The Wednesday May 13, 2020 session is now available on demand.

EVOLVING CONCEPTS IN DERMATOLOGY PART II
Darrell Rigel, MD, MS: New Issues in Photoprotection as the Summer Approaches
Seemal Desai, MD: Janus Kinase Family – JAK 1, 2, 3 & TYK2 and How They Will Impact Your Practice

Log in to Begin Activity

Seemal Desai, MD

Faculty

Clinical Assistant Professor
Department of Dermatology
University of Texas Southwestern Medical Center
Dallas, TX

Darrell Rigel, MD, MS

Faculty

Clinical Professor of Dermatology
New York University School of Medicine
The Ronald O. Perelman Department of Dermatology
New York, NY

Upon completion of this activity, the participant should be better able to:

Present the oxybenzone controversies to patients
Understand the issues and controversies related to photoprotection
Discuss the mechanism of action of janus kinase inhibitor drugs, newer therapeutic and research options, and clinical applications

This activity has been designed for dermatologists, dermatology physician assistants, dermatology nurse practitioners, and other providers involved in the care of patients.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Institute for Continuing Healthcare Education and the Foundation for Research and Education in Dermatology. The Institute is accredited by the ACCME to provide continuing medical education for physicians.

The Institute designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity is supported by educational grants from Almirall, Bristol-Myers Squibb, and Mayne Pharma.

CONFLICTS OF INTEREST/DISCLOSURES

Seemal Desai, MD

Consultant/Independent Contractor: Abbvie Inc., Dermavant Sciences, Inc., Novan, SkinMedica, Symbio, Watson
Grant/Research Support: Dermavant Sciences, Inc., Menlo, Pfizer, Skinceuticals
Speakers Bureau: Pfizer, Skinceuticals

Darrell S. Rigel, MD, MS

Consultant: Castle Biosciences, DermTech, Ortho Dermatologics, Regeneron, and Scibase
Speakers Bureau: Almirall, Castle Biosciences, Ferndale, Johnson & Johnson, Myriad Genetics, Ortho Dermatologics, and Pfizer.

Cathy Pagano (Institute for Continuing Healthcare Education) has disclosed that she has no relevant financial relationships specific to the subject matter within the past 12 months.

Session 5 of 8 Evolving Concepts in Dermatology Part II

Seemal Desai, MD

Darrell Rigel, MD, MS

CONFLICTS OF INTEREST/DISCLOSURES

Session 5 of 8
Evolving Concepts in Dermatology Part II